Very elderly people with nonvalvular atrial fibrillation (Afib) got the same stroke prevention benefits from edoxaban (Savaysa) and apixaban (Eliquis), though one drug was associated with more major ...

CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as warfarin, although this strategy might come at a higher cost of bleeding, ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — For children with rare heart conditions that increase risk for thromboembolism, daily edoxaban may be ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

LISBON, Portugal—Use of uninterrupted edoxaban (Savaysa; Daiichi Sankyo) during catheter ablation for A-fib is associated with rates of thromboembolic and bleeding events that are low and comparable ...

Elderly patients with atrial fibrillation (AF) who are at high risk of bleeding may benefit from a low 15-mg dose of edoxaban, regardless of their frailty status, a subanalysis of the ELDERCARE-AF ...

Treatment with the direct factor Xa inhibitor edoxaban (Lixiana) resulted in low rates of clinically relevant bleeding and thromboembolism (TE) compared with standard-of-care (SOC) anticoagulants in ...

Please provide your email address to receive an email when new articles are posted on . Extended treatment with the oral anticoagulant edoxaban prevented recurrent venous thromboembolism and led to ...

The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients suffering from blood clots in the legs and lungs. NICE has issued a Final Appraisal ...

Edoxaban is recommended, within its marketing authorisation, as an option for preventing stroke and systemic embolism in adults with non‑valvular atrial fibrillation with one or more risk factors, ...

Implementation of appropriate oral anticoagulant treatment for the prevention of stroke in very elderly patients with atrial fibrillation is challenging because of concerns regarding bleeding. We ...

A new study compares edoxaban anticoagulant with the standard of care in large randomized clinical trial. The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or ...